Annual Current Liabilities
$43.81 M
-$516.20 K-1.16%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual total current liabilities is $43.81 million, with the most recent change of -$516.20 thousand (-1.16%) on December 31, 2023.
- During the last 3 years, IPHA annual current liabilities has fallen by -$12.13 million (-21.69%).
- IPHA annual current liabilities is now -80.53% below its all-time high of $225.05 million, reached on December 31, 2018.
Performance
IPHA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$40.97 M
-$2.84 M-6.49%
June 30, 2024
Summary
- As of February 7, 2025, IPHA quarterly total current liabilities is $40.97 million, with the most recent change of -$2.84 million (-6.49%) on June 30, 2024.
- Over the past year, IPHA quarterly current liabilities has increased by +$38.10 thousand (+0.09%).
- IPHA quarterly current liabilities is now -81.79% below its all-time high of $225.05 million, reached on December 31, 2018.
Performance
IPHA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
IPHA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.2% | +0.1% |
| 3 y3 years | -21.7% | +0.1% |
| 5 y5 years | -80.5% | +0.1% |
IPHA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.6% | at low | -54.7% | +0.1% |
| 5 y | 5-year | -67.9% | at low | -55.8% | +0.1% |
| alltime | all time | -80.5% | +1537.6% | -81.8% | +360.1% |
Innate Pharma SA Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $40.97 M(-6.5%) |
| Dec 2023 | $43.81 M(-1.2%) | $43.81 M(+7.0%) |
| Jun 2023 | - | $40.93 M(-7.7%) |
| Dec 2022 | $44.33 M(-51.0%) | $44.33 M(-42.3%) |
| Jun 2022 | - | $76.84 M(-15.0%) |
| Dec 2021 | $90.45 M(+61.7%) | $90.45 M(+78.3%) |
| Jun 2021 | - | $50.72 M(-9.3%) |
| Dec 2020 | $55.95 M(-59.0%) | $55.95 M(-39.6%) |
| Jun 2020 | - | $92.61 M(-32.1%) |
| Dec 2019 | $136.46 M(-39.4%) | $136.46 M(+26.9%) |
| Jun 2019 | - | $107.50 M(-52.2%) |
| Dec 2018 | $225.05 M(+153.8%) | $225.05 M(+189.6%) |
| Jun 2018 | - | $77.72 M(-12.4%) |
| Dec 2017 | $88.67 M(+9.7%) | $88.67 M(+2.0%) |
| Jun 2017 | - | $86.97 M(+7.6%) |
| Dec 2016 | $80.81 M(+22.9%) | $80.81 M(-8.3%) |
| Jun 2016 | - | $88.14 M(+34.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $65.78 M(+402.0%) | $65.78 M(+1.4%) |
| Jun 2015 | - | $64.87 M(+395.1%) |
| Dec 2014 | $13.10 M(+2.3%) | $13.10 M(-24.6%) |
| Jun 2014 | - | $17.37 M(+35.6%) |
| Dec 2013 | $12.81 M(-36.9%) | $12.81 M(-34.3%) |
| Jun 2013 | - | $19.49 M(-4.1%) |
| Dec 2012 | $20.32 M(+1.2%) | $20.32 M(-7.8%) |
| Jun 2012 | - | $22.03 M(+9.8%) |
| Dec 2011 | $20.07 M(+104.6%) | $20.07 M(+75.9%) |
| Jun 2011 | - | $11.41 M(+16.4%) |
| Dec 2010 | $9.81 M(-26.0%) | $9.81 M(+10.1%) |
| Jun 2010 | - | $8.91 M(-32.8%) |
| Dec 2009 | $13.25 M(-26.0%) | $13.25 M |
| Dec 2008 | $17.91 M(+16.4%) | - |
| Dec 2007 | $15.39 M(+16.2%) | - |
| Dec 2006 | $13.24 M(+394.9%) | - |
| Dec 2005 | $2.68 M | - |
FAQ
- What is Innate Pharma SA annual total current liabilities?
- What is the all time high annual current liabilities for Innate Pharma SA?
- What is Innate Pharma SA annual current liabilities year-on-year change?
- What is Innate Pharma SA quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Innate Pharma SA?
- What is Innate Pharma SA quarterly current liabilities year-on-year change?
What is Innate Pharma SA annual total current liabilities?
The current annual current liabilities of IPHA is $43.81 M
What is the all time high annual current liabilities for Innate Pharma SA?
Innate Pharma SA all-time high annual total current liabilities is $225.05 M
What is Innate Pharma SA annual current liabilities year-on-year change?
Over the past year, IPHA annual total current liabilities has changed by -$516.20 K (-1.16%)
What is Innate Pharma SA quarterly total current liabilities?
The current quarterly current liabilities of IPHA is $40.97 M
What is the all time high quarterly current liabilities for Innate Pharma SA?
Innate Pharma SA all-time high quarterly total current liabilities is $225.05 M
What is Innate Pharma SA quarterly current liabilities year-on-year change?
Over the past year, IPHA quarterly total current liabilities has changed by +$38.10 K (+0.09%)